Current Issue
VOL 10 • NO 1 JAN/FEB 2019
This issue’s cover illustration depicts an ultrasound-guided injection of botulinum toxin into the parotid gland for control of salivary dysfunction after surgery for esophageal cancer. Rates of wound dehiscence, infection, and fistula formation are high secondary to hypersalivation. The injection is given in the days prior to surgery and reduces salivary function for about 45 days. Artwork by Alexandra Webber Baker, ©2019, DNA Illustrations, Inc., Asheville, North Carolina.EditorialPamela Hallquist Viale, RN, MS, CNS, ANPStudies regarding safe levels of alcohol consumption are relatively easy to find in the literature. However, the conclusions of the studies vary, and it’s easy to get confused over the most accurate recommendations regarding the consumption of alcohol. In fact, it’s difficult to truly understand ...
Original ResearchRita Musanti, PhD, APN-BC, Ying-Yu Chao, PhD, GNP-BC, and Katelyn Collins, BS, RDNCancer will be diagnosed in approximately 39.6% of men and women during their lifetime, according to data collected by the Surveillance, Epidemiology, and End Results Program (SEER), of the National Cancer Institute (NCI, 2015). Early detection and improved treatments continue to positively impac...
Review ArticleLeah Shaw, MSN, RN, AGPCNP-BC, AOCNP®, Angela F. Bazzell, DNP, RN, FNP-BC, AOCNP®, and Joyce E. Dains, DrPH, JD, RN, FNP-BC, FNAP, FAANPHead and neck cancers (HNC) include those of the oral cavity and pharynx. Oral cavity and pharynx cancers have the eighth highest incidence rate for men in the United States, with an estimated 37,160 new cases in 2018 (Siegel, Miller, & Jemal, 2018). Although the incidence of esophageal cance...
Review ArticleNadia E. K. DePaola, MS, PA-C, and Heather Coggins, MS, PA-CBreast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare peripheral T-cell lymphoma. As a result of incomplete reporting, coupled with the rareness of the disease, understanding its history has been challenging throughout the years. Despite its rarity, BIA-ALCL has gained muc...
Prescriber's CornerTanya J. Uritsky, PharmD, BCPS, CPEThe backbone of treatment for moderate to severe cancer pain is opioids. Opioid-induced constipation (OIC) is a common adverse effect of opioid therapy, affecting 40% to 90% of patients on long-term opioid therapy and can occur even with short-term use (Pergolizzi, 2017). Opioid-induced constipat...
Prescriber's CornerChris Selby,1 PharmD, BCOP, Lisa R. Yacko,2 PharmD, BCPS, and Ashley E. Glode,3 PharmD, BCOPAcute myeloid leukemia (AML) is a malignancy characterized by differentiation abnormalities combined with uncontrolled clonal proliferation that prevents normal bone marrow hematopoiesis. These immature, undifferentiated, malignant cells are often referred to as “blasts,” as they are unable to pr...
Tools and TechnologyKelley D. Mayden, MSN, FNP, AOCNP®, IACToday, oncology advanced practice providers (APP) play a critical role in providing cancer care to millions of patients and families. This is a task most daunting given the volume of research dissemination, technological advancements, and the rising cost of cancer care, all in the age of precisio...
